BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35539596)

  • 1. Biocompatible tumor-targeting nanocomposites based on CuS for tumor imaging and photothermal therapy.
    Liang L; Peng S; Yuan Z; Wei C; He Y; Zheng J; Gu Y; Chen H
    RSC Adv; 2018 Feb; 8(11):6013-6026. PubMed ID: 35539596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near infrared dye loaded copper sulfide-apoferritin for tumor imaging and photothermal therapy.
    He Y; Shen Y; Zhou S; Wu Y; Yuan Z; Wei C; Gui L; Chen Y; Gu Y; Chen H
    RSC Adv; 2018 Apr; 8(26):14268-14279. PubMed ID: 35540767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin-Bioinspired Gd:CuS Nanotheranostic Agent for In Vivo Photoacoustic/Magnetic Resonance Imaging-Guided Tumor-Targeted Photothermal Therapy.
    Yang W; Guo W; Le W; Lv G; Zhang F; Shi L; Wang X; Wang J; Wang S; Chang J; Zhang B
    ACS Nano; 2016 Nov; 10(11):10245-10257. PubMed ID: 27791364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Photothermal effect of nano-copper sulfide against tongue squamous cell carcinoma].
    Chen D; Chen Z; Wang Z; Yang Y; Jiang Y; Hu C
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Dec; 41(12):1843-1849. PubMed ID: 35012917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BSA-directed synthesis of CuS nanoparticles as a biocompatible photothermal agent for tumor ablation in vivo.
    Zhang C; Fu YY; Zhang X; Yu C; Zhao Y; Sun SK
    Dalton Trans; 2015 Aug; 44(29):13112-8. PubMed ID: 26106950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermosensitive drug-loading system based on copper sulfide nanoparticles for combined photothermal therapy and chemotherapy in vivo.
    Yuan Z; Qu S; He Y; Xu Y; Liang L; Zhou X; Gui L; Gu Y; Chen H
    Biomater Sci; 2018 Nov; 6(12):3219-3230. PubMed ID: 30255863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the therapeutic efficacy of radiolabeled BSA@CuS nanoparticle-induced radio-photothermal therapy against anaplastic thyroid cancer.
    Zhang C; Chai J; Jia Q; Tan J; Meng Z; Li N; Yuan M
    IUBMB Life; 2022 May; 74(5):433-445. PubMed ID: 35112451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasmall hybrid protein-copper sulfide nanoparticles for targeted photoacoustic imaging of orthotopic hepatocellular carcinoma with a high signal-to-noise ratio.
    Yan H; Chen J; Li Y; Bai Y; Wu Y; Sheng Z; Song L; Liu C; Zhang H
    Biomater Sci; 2018 Dec; 7(1):92-103. PubMed ID: 30358774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ultrasmall Biocompatible CuS@BSA Nanoparticle and Its Photothermal Effects.
    Wan X; Liu M; Ma M; Chen D; Wu N; Li L; Li Z; Lin G; Wang X; Xu G
    Front Pharmacol; 2019; 10():141. PubMed ID: 30863310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-targeting CuS nanoparticles for multimodal imaging and guided photothermal therapy of lymph node metastasis.
    Shi H; Yan R; Wu L; Sun Y; Liu S; Zhou Z; He J; Ye D
    Acta Biomater; 2018 May; 72():256-265. PubMed ID: 29588255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatible copper sulfide-based nanocomposites for artery interventional chemo-photothermal therapy of orthotropic hepatocellular carcinoma.
    Li X; Yuan HJ; Tian XM; Tang J; Liu LF; Liu FY
    Mater Today Bio; 2021 Sep; 12():100128. PubMed ID: 34632360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong Near-Infrared Absorbing and Biocompatible CuS Nanoparticles for Rapid and Efficient Photothermal Ablation of Gram-Positive and -Negative Bacteria.
    Huang J; Zhou J; Zhuang J; Gao H; Huang D; Wang L; Wu W; Li Q; Yang DP; Han MY
    ACS Appl Mater Interfaces; 2017 Oct; 9(42):36606-36614. PubMed ID: 28976189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photothermal effects of CuS-BSA nanoparticles on H22 hepatoma-bearing mice.
    Dun X; Liu S; Ge N; Liu M; Li M; Zhang J; Bao H; Li B; Zhang H; Cui L
    Front Pharmacol; 2022; 13():1029986. PubMed ID: 36313308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal Photothermal Sterilization and Abscess Elimination Research of BSA-CuS Nanoparticles in vivo.
    Zhao Y; Zhao JJ; Guo JX; Liu SQ; Li Y; Wang XY; Li R; Tang HQ; Li ZY; Yang HF; Chen B
    ChemMedChem; 2022 Feb; 17(3):e202100570. PubMed ID: 34719851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of copper vacancy defects in a silver-doped CuS nanoplatform for high-efficiency photothermal-chemodynamic synergistic antitumor therapy.
    Qin Z; Qiu M; Zhang Q; Yang S; Liao G; Xiong Z; Xu Z
    J Mater Chem B; 2021 Nov; 9(42):8882-8896. PubMed ID: 34693959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocompatible CuS-based nanoplatforms for efficient photothermal therapy and chemotherapy in vivo.
    Peng S; He Y; Er M; Sheng Y; Gu Y; Chen H
    Biomater Sci; 2017 Feb; 5(3):475-484. PubMed ID: 28078340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hollow Mesoporous Silica Nanoparticles Gated by Chitosan-Copper Sulfide Composites as Theranostic Agents for the Treatment of Breast Cancer.
    Niu S; Zhang X; Williams GR; Wu J; Gao F; Fu Z; Chen X; Lu S; Zhu LM
    Acta Biomater; 2021 May; 126():408-420. PubMed ID: 33731303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifouling Dendrimer-Entrapped Copper Sulfide Nanoparticles Enable Photoacoustic Imaging-Guided Targeted Combination Therapy of Tumors and Tumor Metastasis.
    Ouyang Z; Li D; Xiong Z; Song C; Gao Y; Liu R; Shen M; Shi X
    ACS Appl Mater Interfaces; 2021 Feb; 13(5):6069-6080. PubMed ID: 33501834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CuS@BSA-NB2 Nanoparticles for HER2-Targeted Photothermal Therapy.
    Ying M; Li Q; Wu J; Jiang Y; Xu Z; Ma M; Xu G
    Front Pharmacol; 2021; 12():779591. PubMed ID: 35126119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metallopeptidase 2 targeted delivery of gold nanostars decorated with IR-780 iodide for dual-modal imaging and enhanced photothermal/photodynamic therapy.
    Xia F; Niu J; Hong Y; Li C; Cao W; Wang L; Hou W; Liu Y; Cui D
    Acta Biomater; 2019 Apr; 89():289-299. PubMed ID: 30851455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.